U.S. Customs and Border Protection (CBP) continues to seize many shipments of counterfeit, unapproved or other COVID-19 products of questionable quality.
At the beginning of June 2020, CBP has seized the following COVID-19 related items:
107,300 FDA-prohibited COVID-19 test kits in 301 incidents;
750,000 counterfeit face masks in 86 incidents;
2,500 EPA-prohibited anti-virus lanyards in 89 incidents; and
11,000 FDA-prohibited chloroquine tablets in 91 incidents.
In addition to the risk of using non-FDA approved drugs, CBP claims the sale of counterfeit COVID-19 goods benefit organized crime.